EMA Validation

Advertisement

cGxPJobs Banner

Eisai Nuvation Taletrectinib EMA MAA Validation

Tokyo & New York – March 27, 2026 Eisai and Nuvation Bio announced that the European Medicines Agency (EMA)...

By cGxPwire Editor
March 27, 2026

Read More

EMA Validates ENHERTU Combo for First-Line HER2 Breast Cancer

TOKYO and MUNICH | January 19, 2026 — Daiichi Sankyo and AstraZeneca announced that the European Medicines Agency (EMA)...

By cGxPwire Editor
January 20, 2026

Read More

Advertisement

cGxPJobs

Directory